Literature DB >> 19958354

Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets.

Maria-Eugenia Chollet, Jean-Philippe Brouland, Claire Bal dit Sollier, Frédéric Bauduer, Ludovic Drouet, Sylvia Bellucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19958354     DOI： 10.1111/j.1365-2141.2009.07989.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.

Authors:  J H Kang; H M Ko; J S Moon; H I Yoo; J Y Jung; M S Kim; J T Koh; W J Kim; S H Kim
Journal:  J Dent Res       Date:  2014-09-25       Impact factor: 6.116

Review 2.  Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.

Authors:  Jochen G Schneider; Sarah R Amend; Katherine N Weilbaecher
Journal:  Bone       Date:  2010-09-17       Impact factor: 4.398

Review 3.  Cancer to bone: a fatal attraction.

Authors:  Katherine N Weilbaecher; Theresa A Guise; Laurie K McCauley
Journal:  Nat Rev Cancer       Date:  2011-05-19       Impact factor: 60.716

Review 4.  Osteoprotegerin in Cardiometabolic Disorders.

Authors:  C Pérez de Ciriza; A Lawrie; N Varo
Journal:  Int J Endocrinol       Date:  2015-05-11       Impact factor: 3.257

5.  Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis.

Authors:  De-Hua Song; Peng-Zhen Zhou; Xiao-Lin Xiu; Guang-Hui Zhou; Yu-Xia Sun; Chun Song
Journal:  Med Sci Monit       Date:  2016-04-12

6.  Osteoprotegerin Induces CD34+ Differentiation in Endothelial Progenitor Cells.

Authors:  Catherine Boisson-Vidal; Zahia Benslimane-Ahmim; Anna Lokajczyk; Dominique Heymann; David M Smadja
Journal:  Front Med (Lausanne)       Date:  2018-11-27

7.  Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13.

Authors:  Kis Djamiatun; Andre J A M van der Ven; Philip G de Groot; Sultana M H Faradz; D Hapsari; Wil M V Dolmans; Silvie Sebastian; Rob Fijnheer; Quirijn de Mast
Journal:  PLoS Negl Trop Dis       Date:  2012-05-01

Review 8.  Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications.

Authors:  Mette Bjerre
Journal:  Springerplus       Date:  2013-12-06

9.  OPG rs2073617 polymorphism is associated with upregulated OPG protein expression and an increased risk of intervertebral disc degeneration.

Authors:  Jing-Bo Xue; Xin-Li Zhan; Wen-Jun Wang; Yi-Guo Yan; Chong Liu
Journal:  Exp Ther Med       Date:  2016-05-16       Impact factor: 2.447

10.  Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.

Authors:  Thor Ueland; Axel Åkerblom; Tatevik Ghukasyan; Annika E Michelsen; Pål Aukrust; Richard C Becker; Maria Bertilsson; Anders Himmelmann; Stefan K James; Agneta Siegbahn; Robert F Storey; Frederic Kontny; Lars Wallentin
Journal:  J Am Heart Assoc       Date:  2018-01-12       Impact factor: 5.501
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.